| Literature DB >> 36064353 |
Carla M Martín-Abreu1, Raquel Hernández1, Patricia Cruz-Castellanos2, Ana Fernández-Montes3, David Lorente-Estellés4, Helena López-Ceballos5, Lorena Ostios-Garcia2, Mónica Antoñanzas6, Paula Jiménez-Fonseca7, Teresa García-García8, Caterina Calderon9.
Abstract
INTRODUCTION: Most cancers occur in older individuals, who are more vulnerable due to functional impairment, multiple comorbidities, cognitive impairment, and lack of socio-familial support. These can undermine patients' sense of dignity. This study seeks to compare dignity scores in older patients with advanced cancer on sociodemographic and clinical variables and analyze the predictive value of anxiety, depression, functional limitations, and social support on dignity scores.Entities:
Keywords: Anxiety; Dignity; Functional limitations; Neoplasm; Social support
Mesh:
Year: 2022 PMID: 36064353 PMCID: PMC9446795 DOI: 10.1186/s12877-022-03423-7
Source DB: PubMed Journal: BMC Geriatr ISSN: 1471-2318 Impact factor: 4.070
Baseline characteristics and dignity score (n = 180)
| Variables | n (%) | Dignity score | Statistics | ||
|---|---|---|---|---|---|
| t/f | |||||
| Male | 98 (54) | 59.6 (8.7) | 2.587 | ||
| Female | 82 (46) | 55.9 (10.5) | |||
| 70-80 | 137 (76) | 57.8 (10.1) | −0.244 | 0.808 | |
| > 80 | 73 (24) | 58.2 (8.0) | |||
| Married or partnered | 146 (69) | 57.8 (10.1) | 0.208 | 0.836 | |
| No partnered | 34 (17) | 57.2 (7.3) | |||
| Primary school or less | 112 (62) | 56.7 (9.8) | −2.152 | ||
| High school or greater | 68 (38) | 59.9 (9.4) | |||
| Broncho-pulmonary | 50 (28) | 57.4 (11.1) | 0.574 | 0.720 | |
| Colorectal | 28 (16) | 59.1 (9.5) | |||
| Pancreas | 30 (17) | 56.2 (9.8) | |||
| Breast | 4 (2) | 54.0 (9.5) | |||
| Stomach | 9 (5) | 57.4 (9.8) | |||
| Others | 59 (33) | 59.0 (8.6) | |||
| Adenocarcinoma | 115 (64) | 57.3 (10.1) | −1.130 | 0.260 | |
| Others | 65 (36) | 59.0 (8.9) | |||
| Locally advanced | 35 (19) | 57.9 (8.9) | −0.003 | 0.998 | |
| IV | 145 (81) | 57.9 (9.9) | |||
| < 18 | 96 (53) | 56.5 (8.8) | −2.105 | ||
| ≥18 | 84 (47) | 59.5 (10.5) | |||
| Chemoterapy (CT) | 102 (57) | 56.7 (9.6) | 2.146 | 0.062 | |
| CT + targeted therapy | 18 (10) | 61.1 (8.7) | |||
| CT + immunotherapy | 11 (6) | 63.7 (11.0) | |||
| Immunotherapy | 20 (11) | 54.9 (10.6) | |||
| Targeted therapy | 9 (5) | 61.2 (7.6) | |||
| Others | 20 (11) | 59.4 (9.0) | |||
| ≤4 | 58 (32) | 57.4 (9.8) | −0.481 | 0.631 | |
| > 4 | 122 (68) | 58.1 (9.7) | |||
| 0-1 | 162 (27) | 58.2 (9.8) | 1.119 | 0.265 | |
| 2-3 | 18 (72.8) | 55.5 (9.1) | |||
Bold values indicate significance at the 5% level
Abbreviations: Eastern Cooperative Oncology Group (ECOG)
Pearson’s correlations between psychological, socio-demographic and clinical variables
| Variables | 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
|---|---|---|---|---|---|---|---|---|
| 1. PPDS. Dignity | 1 | |||||||
| 2. BSI. Anxiety | 1 | |||||||
| 3. BSI. Depression | 1 | |||||||
| 4. DUKE. Social Support | −0.041 | −0.142 | 1 | |||||
| 5. EORTC-QLQ-C30. Functional scale | 1 | |||||||
| 6. Sex: male | 0.129 | 1 | ||||||
| 7. Higher educational level | − 0.047 | − 0.022 | 1 | |||||
| 8. Estimated survival ≥18 months | −.022 | −0.078 | 0.115 | −0.006 | 0.144 | 1 |
Abbreviations: PPDS Palliative Patient’s Dignity Scale, BSI Brief Symptom Inventory, DUKE Duke–UNC-11 Functional Social Support Questionnaire, EORTC-QLQ-C30 European Organization for Research and Treatment of Cancer Quality of Life C-30 questionnaire
*p < 0.01 (two-tailed); **p < 0.001 (two-tailed)
Linear regression models for dignity and sex
| PPDS-Dignity score | |||||
|---|---|---|---|---|---|
| Predictor | B | 95%Cl | |||
| For men (Constant) | 50.357 | 5.283 | 31.42 – 69.29 | ||
| BSI. Anxiety | −0.177 | −0.171 | −1.365 | 0.175 | −0.43 – 0.08 |
| BSI. Depression | −0.147 | −0.115 | − 0.973 | 0.333 | − 0.45 – 0.15 |
| DUKE. Social Support | 0.515 | 0.385 | 4.564 | 0.29 – 0.73 | |
| EORTC-QLQ-C30. Functional Scale | 0.084 | 0.236 | 2.474 | −0.01 – 0.15 | |
| Higher educational level | 3.234 | 0.181 | 2.243 | 0.19– 6.27 | |
| Estimated survival ≥18 months | −0.230 | −0.013 | − 0.155 | 0.877 | −3.18 – 2.72 |
| 0.403 | |||||
| For women (Constant) | 75.336 | 5.608 | 48.57 – 96.98 | ||
| BSI. Anxiety | −0.164 | −0.162 | −1.119 | 0.267 | −0.45 – 0.13 |
| BSI. Depression | −0.545 | −0.380 | −2.876 | −0.92 – 0.16 | |
| DUKE. Social Support | 0.434 | 0.240 | 3.271 | 0.17 – 0.69 | |
| EORTC-QLQ-C30. Functional Scale | 0.107 | 0.246 | 2.401 | −0.02 – 0.19 | |
| Higher educational level | −1.304 | −0.060 | −0.854 | 0.396 | −4.34– 1.74 |
| Estimated survival ≥18 months | 2.661 | 0.127 | 1.744 | 0.085 | −0.37 – 5.70 |
| 0.610 | |||||
Abbreviations: PPDS Palliative Patient’s Dignity Scale, BSI Brief Symptom Inventory, DUKE Duke–UNC-11 Functional Social Support Questionnaire, EORTC-QLQ-C30 European Organization for Research and Treatment of Cancer Quality of Life C-30 questionnaire, CI confidence interval. Bold values indicate significance the at 5% level